Mirum Pharmaceuticals Inc Sustainability Reports
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating rare liver diseases. Its products include maralixibat (LIVMARLI), volixibat, Cholbam, and Chenodal.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900YZKR40F7F27K81
FIGI: BBG00MH7T2N6
4 reports from 2020 to 2024
